Updating the therapeutic role of ginsenosides in breast cancer: a bibliometrics study to an in-depth review

Breast cancer is currently the most common malignancy and has a high mortality rate. Ginsenosides, the primary bioactive constituents of ginseng, have been shown to be highly effective against breast cancer both in vitro and in vivo. This study aims to comprehensively understand the mechanisms underlying the antineoplastic effects of ginsenosides on breast cancer. Through meticulous bibliometric analysis and an exhaustive review of pertinent research, we explore and summarize the mechanism of action of ginsenosides in treating breast cancer, including inducing apoptosis, autophagy, inhibiting epithelial-mesenchymal transition and metastasis, and regulating miRNA and lncRNA. This scholarly endeavor not only provides novel prospects for the application of ginsenosides in the treatment of breast cancer but also suggests future research directions for researchers.

• Publication year

  2023

• Venue

  Frontiers in Pharmacology

• Publication date

  2023-09-25

• Fields of study

  Medicine

• Identifiers
  DOI 10.3389/fphar.2023.1226629PMID 37818185PMCID 10560733
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The role of epigenetic modifications in drug resistance and treatment of breast cancer

  2022cited by this paper
• Beneficial and detrimental aspects of miRNAs as chief players in breast cancer: A comprehensive review.

  2022cited by this paper
• EMT mechanism in breast cancer metastasis and drug resistance: Revisiting molecular interactions and biological functions.

  2022cited by this paper
• Overview of MicroRNAs as Diagnostic and Prognostic Biomarkers for High-Incidence Cancers in 2021

  2022cited by this paper
• Relationship between Autophagy and Drug Resistance in Tumors.

  2022cited by this paper
• Versatile ginsenoside Rg3 liposomes inhibit tumor metastasis by capturing circulating tumor cells and destroying metastatic niches

  2022cited by this paper
• Ginsenoside Rh2 inhibits breast cancer cell growth viaERβ-TNFα pathway

  2022cited by this paper
• Breast Cancer in Asia: Incidence, Mortality, Early Detection, Mammography Programs, and Risk-Based Screening Initiatives

  2022cited by this paper
• Ginsenoside Rh2 Regulates the CFAP20DC-AS1/MicroRNA-3614-3p/BBX and TNFAIP3 Axis to Induce Apoptosis in Breast Cancer Cells.

  2022cited by this paper
• Ginsenoside Rh1 Induces MCF-7 Cell Apoptosis and Autophagic Cell Death through ROS-Mediated Akt Signaling

  2021cited by this paper
• Ginsenoside Rh2 reduces m6A RNA methylation in cancer via the KIF26B-SRF positive feedback loop

  2021cited by this paper
• Ginsenoside Rh2 upregulates long noncoding RNA STXBP5-AS1 to sponge microRNA-4425 in suppressing breast cancer cell proliferation

  2021cited by this paper
• MicroRNA-424-5p enhances chemosensitivity of breast cancer cells to Taxol and regulates cell cycle, apoptosis, and proliferation

  2021cited by this paper
• Ginsenoside (20S)-protopanaxatriol induces non-protective autophagy and apoptosis by inhibiting Akt/mTOR signaling pathway in triple-negative breast cancer cells.

  2021cited by this paper
• The Apolipoprotein C1 is involved in breast cancer progression via EMT and MAPK/JNK pathway.

  2021cited by this paper
• Current Status and Research Trends of Panax Between 1900–2019: A Bibliometric Analysis

  2021cited by this paper
• Ginsenoside Rg3 Prevents Oncogenic Long Noncoding RNA ATXN8OS from Inhibiting Tumor-Suppressive microRNA-424-5p in Breast Cancer Cells

  2021cited by this paper
• Role of myeloid-derived suppressor cells in metastasis

  2021cited by this paper
• Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

  2021cited by this paper
• Ginsenoside Rg2 protects cardiomyocytes against trastuzumab-induced toxicity by inducing autophagy

  2021cited by this paper
• Pharmacological potential of ginseng and its major component ginsenosides

  2020cited by this paper
• The Roles of Cyclin-Dependent Kinases in Cell-Cycle Progression and Therapeutic Strategies in Human Breast Cancer

  2020cited by this paper
• Bibliometric analysis of breast cancer research in the period 2009-2018.

  2020cited by this paper
• Overall survival of CDK4/6-inhibitors-based treatments in clinically relevant subgroups of metastatic breast cancer: systematic review and meta-analysis.

  2020cited by this paper
• 20(S)-Rg3 upregulates FDFT1 via reducing miR-4425 to inhibit ovarian cancer progression.

  2020cited by this paper
• Targeting Cell Cycle in Breast Cancer: CDK4/6 Inhibitors

  2020cited by this paper
• Inhibitory effect of ginsenoside Rg3 on cancer stemness and mesenchymal transition in breast cancer via regulation of myeloid-derived suppressor cells

  2020cited by this paper
• Ginsenoside Rg1 Induces Apoptotic Cell Death in Triple-Negative Breast Cancer Cell Lines and Prevents Carcinogen-Induced Breast Tumorigenesis in Sprague Dawley Rats

  2020cited by this paper
• Management of Ductal Carcinoma In Situ (DCIS) of the Breast: Present Approaches and Future Directions

  2019cited by this paper
• Ginsenoside Rk1 induces cell cycle arrest and apoptosis in MDA-MB-231 triple negative breast cancer cells.

  2019cited by this paper
• Epigenetic modifications of histones in cancer

  2019cited by this paper
• Autophagy in Cancer Cell Death

  2019cited by this paper
• Ginsenoside Rg3 and Korean Red Ginseng extract epigenetically regulate the tumor-related long noncoding RNAs RFX3-AS1 and STXBP5-AS1

  2019cited by this paper
• Long non‐coding RNA HCG11 suppresses the growth of glioma by cooperating with the miR‐4425/MTA3 axis

  2019cited by this paper
• Ginsenoside 20(S)‐protopanaxadiol inhibits triple‐negative breast cancer metastasis in vivo by targeting EGFR‐mediated MAPK pathway

  2019cited by this paper
• Ginsenoside Rg5 induces apoptosis and autophagy via the inhibition of the PI3K/Akt pathway against breast cancer in a mouse model.

  2018cited by this paper
• The anti-tumor effect of ginsenoside Rh4 in MCF-7 breast cancer cells in vitro and in vivo.

  2018cited by this paper
• 20(S)-Protopanaxadiol-Induced Apoptosis in MCF-7 Breast Cancer Cell Line through the Inhibition of PI3K/AKT/mTOR Signaling Pathway

  2018cited by this paper
• Genome-Wide Methylation Analysis Identifies NOX4 and KDM5A as Key Regulators in Inhibiting Breast Cancer Cell Proliferation by Ginsenoside Rg3.

  2018cited by this paper
• Myeloid‐derived suppressor cells: Important contributors to tumor progression and metastasis

  2018cited by this paper
• Targeting autophagy in cancer

  2018cited by this paper
• Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2016

  2018cited by this paper
• Reducing histone acetylation rescues cognitive deficits in a mouse model of Fragile X syndrome

  2018cited by this paper
• Polyubiquitination inhibition of estrogen receptor alpha and its implications in breast cancer

  2018cited by this paper
• Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 2006 to 2016: A systematic analysis for the Global Burden of Disease study.

  2018cited by this paper
• Ginsenoside Rd regulates the Akt/mTOR/p70S6K signaling cascade and suppresses angiogenesis and breast tumor growth.

  2017cited by this paper
• Ginsenoside Rg3 promotes cytotoxicity of Paclitaxel through inhibiting NF-κB signaling and regulating Bax/Bcl-2 expression on triple-negative breast cancer.

  2017cited by this paper
• Ginsenoside Rh2 epigenetically regulates cell-mediated immune pathway to inhibit proliferation of MCF-7 breast cancer cells

  2017cited by this paper
• MECP2 promotes the growth of gastric cancer cells by suppressing miR-338-mediated antiproliferative effect

  2016cited by this paper
• Ginsenoside Rd attenuates breast cancer metastasis implicating derepressing microRNA-18a-regulated Smad2 expression

  2016cited by this paper
• Effects of ginsenoside compound K combined with cisplatin on the proliferation, apoptosis and epithelial mesenchymal transition in MCF-7 cells of human breast cancer

  2016cited by this paper
• Competing endogenous RNA networks in human cancer: hypothesis, validation, and perspectives

  2016cited by this paper
• The role of deubiquitinases in breast cancer

  2016cited by this paper
• EMT in Breast Carcinoma—A Review

  2016cited by this paper
• Role of epigenetic modifications in luminal breast cancer.

  2015cited by this paper
• Ginsenoside Rh2 differentially mediates microRNA expression to prevent chemoresistance of breast cancer.

  2015cited by this paper
• The Role of Methylation in Breast Cancer Susceptibility and Treatment.

  2015cited by this paper
• EMT, CTCs and CSCs in tumor relapse and drug-resistance

  2015cited by this paper
• The cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, HER2-negative, advanced breast cancer (PALOMA-1/TRIO-18): a randomised phase 2 study.

  2015cited by this paper
• Roles of lncRNA in breast cancer.

  2015cited by this paper
• The role for autophagy in cancer.

  2015cited by this paper
• EMT and EGFR in CTCs cytokeratin negative non-metastatic breast cancer

  2014cited by this paper
• Targeting Cell-Intrinsic and Cell-Extrinsic Mechanisms of Intravasation in Invasive Breast Cancer

  2014cited by this paper
• SNAI1 is critical for the aggressiveness of prostate cancer cells with low E-cadherin

  2014cited by this paper
• Ginsenoside Rg3 Inhibits Constitutive Activation of NF-κB Signaling in Human Breast Cancer (MDA-MB-231) Cells: ERK and Akt as Potential Upstream Targets

  2014cited by this paper
• Anti-breast cancer activity of Fine Black ginseng (Panax ginseng Meyer) and ginsenoside Rg5

  2014cited by this paper
• Targeting BIG3–PHB2 interaction to overcome tamoxifen resistance in breast cancer cells

  2013cited by this paper
• MDM2 Promotes Invasion and Metastasis in Invasive Ductal Breast Carcinoma by Inducing Matrix Metalloproteinase-9

  2013cited by this paper
• Targeting autophagy

  2012cited by this paper
• Key Role of Nuclear Factor-κB in the Cellular Pharmacokinetics of Adriamycin in MCF-7/Adr Cells: The Potential Mechanism for Synergy with 20(S)-Ginsenoside Rh2

  2012cited by this paper
• Regulation of EMT by TGFβ in cancer

  2012cited by this paper
• Ginsenoside F2 induces apoptosis accompanied by protective autophagy in breast cancer stem cells.

  2012cited by this paper
• Natural Product Ginsenoside 25-OCH3-PPD Inhibits Breast Cancer Growth and Metastasis through Down-Regulating MDM2

  2012cited by this paper
• Curcumin: A review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma

  2011cited by this paper
• Ginsenoside Rp1 from Panax ginseng Exhibits Anti-cancer Activity by Down-regulation of the IGF-1R/Akt Pathway in Breast Cancer Cells

  2011cited by this paper
• Ginsenoside Rh2 induces Bcl‐2 family proteins‐mediated apoptosis in vitro and in xenografts in vivo models

  2011cited by this paper
• Zinc finger protein ZBTB20 expression is increased in hepatocellular carcinoma and associated with poor prognosis

  2011cited by this paper
• Increased Slug and decreased E-cadherin expression is related to poor prognosis in patients with gastric cancer

  2011cited by this paper
• Matrix Metalloproteinase-Induced Epithelial-Mesenchymal Transition in Breast Cancer

  2010cited by this paper
• Increased Ubiquitination of Multidrug Resistance 1 by Ginsenoside Rd

  2010cited by this paper
• Epigenetic Modifications as Therapeutic Targets

  2010cited by this paper
• Intraductal proliferative lesions of the breast: morphology, associated risk and molecular biology

  2010cited by this paper
• Role of autophagy in cancer

  2007cited by this paper
• MDM2 and human malignancies: expression, clinical pathology, prognostic markers, and implications for chemotherapy.

  2005cited by this paper
• Specific inhibition of cyclin-dependent kinase 4/6 by PD 0332991 and associated antitumor activity in human tumor xenografts.

  2004cited by this paper

• Cellular senescence in cancer: Friend or fraud?

  2026cites this paper
• Botanical Adjuvants in Oncology: A Review on Natural Compounds in Synergy with Conventional Therapies as Next-Generation Enhancers of Breast Cancer Treatment.

  2026cites this paper
• Multifaceted Elucidation of the BARD1‐Targeting Mechanism of Natural Ginsenosides Through Molecular Docking, Molecular Dynamics Simulations, DFT Calculations, and MM/PBSA Analyses

  2026cites this paper
• Exploring New Frontiers: Alternative Breast Cancer Treatments Through Glycocalyx Research

  2025cites this paper
• Triterpenes in breast cancer: a systematic review of preclinical evidence in rodents

  2025cites this paper
• Applications of bioactive compounds of traditional Chinese medicine in breast cancer management

  2025cites this paper
• Ginsenoside Rg3 in Cancer Research: Current Trends and Future Prospects - A Review.

  2025cites this paper
• Research trends in essential thrombocythemia from 2001 to 2024: a bibliometric analysis

  2025cites this paper
• Human disease-related long noncoding RNAs: Impact of ginsenosides

  2024cites this paper
• Evaluation of antioxidant, anti-inflammatory and cytotoxic potential of phytochemicals from Gymnostachyum febrifugum-an in vitro study

  2024cites this paper